Although IL-18/p38 MAPK pathway downregulates claudin-12 and promotes tumor invasion in breast cancer, indicating its possible anti-tumor effect (121), the upregulation of claudin-12 in colorectal cancer needs to be further studied (76). Here, IL18 is linked to neoplasm.